EndoTool Glucose Management System
The only patient-specific insulin dosing system for inpatient glycemic management
Software · On PremiseCompany source
Company profile
About Glooko
Glooko is a diabetes management platform that aggregates data from glucose meters, CGMs, and insulin pumps to provide AI-driven insights for patients and clinicians.
Company description Glooko official website
Primary marketChronic Disease Management & Digital Therapeutics
Commercial modelCommercial information available on request
Work at Glooko?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- diabetes
- hyperglycemia
- inpatient glycemic management
Who it serves
- Clinics
- Healthcare Providers
- Hospitals & Health Systems
- Life Sciences
- People with Diabetes
Deployment & integration
Api Only · Cloud Saas · On Premise deployment with recorded integration context.
Recorded integration context: 200+ diabetes and health monitoring devices, EHR systems, Roche Accu-Chek SmartGuide CGM.
Geographic context
MarketsEuropean countries · Global · multiple countries worldwide · United States
Company sourceOfficial website
Company milestones
Platform expansion
Acquired Monarch Medical Technologies to expand into inpatient glycemic management; Won Best Overall MedTech Software in 2026 MedTech Breakthrough Awards; Integrated with Roche Accu-Chek SmartGuide CGM in select European countries; Launched refreshed Glooko Mobile App; Released new clinic dashboard for population health management
Partnerships
Recorded partners
- Monarch Medical Technologies (acquired)
- Roche Accu-Chek
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
Glooko API & EHR Integration Portal
API and EHR integration capabilities for diabetes data
Api · Api OnlyCompany source
Glooko Diabetes Management Platform
Simplifying diabetes care through seamless device integration and actionable insights
Platform · Cloud SaaSCompany source
Glooko Mobile App
Comprehensive diabetes and health data tracking for people living with diabetes
Software · Cloud SaaSCompany source
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
Fear of Nighttime Hypoglycemia: Perspectives of Diabetes Providers and Caregivers.Journal of clinical psychology in medical settings · Jul 18, 2026
Integrating the Glycemia Risk Index Into Clinical Practice and Research: A Consensus Report.Journal of diabetes science and technology · May 1, 2026
Research Code Sharing in Support of Gold Standard Science.Journal of diabetes science and technology · May 1, 2026
Using Digital Health Technology to Prevent and Treat Diabetes.Diabetes technology & therapeutics · Mar 1, 2026
Closed-Loop, Decision Support, and Artificial Intelligence.Diabetes technology & therapeutics · Mar 1, 2026
iCoDE-2 September 18, 2025 Steering Committee Final Meeting Summary Report.Journal of diabetes science and technology · Jan 1, 2026
Clinical validation
Clinical-trial records
A Study of LY8888AX in Participants Using a Connected Insulin Management PlatformNCT05893797 · Mentioned · COMPLETED
Feasibility Study of a Behavioral Parent Intervention to Support Self-management in Pediatric Typ 1 DiabetesNCT06599840 · Mentioned · ACTIVE NOT RECRUITING
Gestational Diabetes After Gastric Bypass SurgeryNCT06291766 · Mentioned · RECRUITING
The Artificial Pancreas in Very Young Children With T1DNCT03784027 · Sponsor · COMPLETED
REACHOUT Mental Health Support Mobile AppNCT05668507 · Mentioned · ACTIVE NOT RECRUITING
24-hour Movement Behaviors in Adults With Type 1 DiabetesNCT06425640 · Mentioned · UNKNOWN
Regulatory
Regulatory records
No linked records are currently available.
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
Average blood glucose reduction
Percentage reduction in 3 months
HbA1c reduction
1 point reduction in 3 months
Hyperglycemic events
2% drop in 3 months
Sustained outcomes
Results maintained over 12 months
Real-world diabetes management study
Diabetes management through mobile health app engagement
Reduction in average blood glucose in 3 months, 2% drop in hyperglycemic events in 3 months
Real-world remote patient monitoring study
Remote patient monitoring for diabetes management
1 point reduction in HbA1c in 3 months, sustained outcomes over 12 months
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
Mark Laret
Member Board of Directors
Rich Glenn
President, Connected Care
Tracy Cannon
Regional Vice President - Southeast
Kevin Brubaker
Vice President, National and Strategic Accounts
Julia Fuller
Vice President, Corporate Communications & Brand
Mark Beucler
Chief Financial Officer
Mark Clements, MD PhD
Chief Medical and Strategy Officer
Gordan Glavaš
Head of Clinical Research & Development
06 · Company updates
Updates from Glooko
Recent articles published on Glooko's official website.
Advancing Connected Diabetes Management with mylife Diabetes Care
Read on GlookoThe ROI of EHR-Integrated Diabetes Data
Read on GlookoLeading the Way in Digital Health Security: Glooko’s Latest Certifications
Read on GlookoADCES 2026: How Glooko Optimizes the CDCES Workflow
Read on GlookoEHR-Integrated Diabetes Care at Scale: A More Holistic, Data-Driven Approach Across the Continuum
Read on Glooko07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Chronic Disease Management & Digital Therapeutics
Companies using AI and digital health tools to help patients manage chronic conditions through digital therapeutics, gamified health management, and AI-powered coaching. Covers management of all chronic diseases including diabetes, hypertension, COPD, heart disease, and multi-condition platforms. Includes continuous glucose monitoring (CGM) systems with AI analytics and insulin optimization algorithms.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.